ORAMED PHARMACEUTICALS INC (ORMP) Institutional Ownership Changes & 13F Activity
ORAMED PHARMACEUTICALS INC (ORMP). Institutional ownership data tracks hedge funds, asset managers, and other institutional investors based on recent SEC Form 13F filings (Q2 2026). This page analyzes institutional buying and selling activity, new holdings, and sold-out positions in the latest reporting period. Notable filers include Mercer Global Advisors Inc, Goldman Sachs Group Inc, Vanguard Portfolio Management Llc, Northern Trust Corp, and Marshall Wace, Llp.
| Institution | Type | Change in shares | Change Position % | Shares | Reported stock balance | Portfolio quarter | Filing date |
|---|---|---|---|---|---|---|---|
| Citadel Advisors Llc | Sell | -57,064 | -57.9% | 41,565 | $199.93K | Q2 2026 | Sep 02, 2026 |
| Mercer Global Advisors Inc | Buy | +1,900,000 | +99.4% | 3,810,540 | $18.33M | Q2 2026 | Aug 19, 2026 |
| Caitlin John, Llc | Buy | +1,000 | — | 1,000 | $4.81K | Q2 2026 | Aug 17, 2026 |
| Goldman Sachs Group Inc | Buy | +253,293 | — | 253,293 | $1.22M | Q2 2026 | Aug 14, 2026 |
| Susquehanna International Group, Llp | Sell | -113,918 | -83.6% | 22,300 | $107.26K | Q2 2026 | Aug 14, 2026 |
| Charles Schwab Investment Management Inc | Buy | +83,634 | — | 83,634 | $402.28K | Q2 2026 | Aug 14, 2026 |
| Hrt Financial Lp | Buy | +70,084 | +254.9% | 97,582 | $469.00K | Q2 2026 | Aug 14, 2026 |
| Jane Street Group, Llc | Buy | +60,809 | +115.7% | 113,349 | $545.21K | Q2 2026 | Aug 14, 2026 |
| Hudson Bay Capital Management Lp | Sell | -41,405 | -80.1% | 10,265 | $49.38K | Q2 2026 | Aug 14, 2026 |
| Price T Rowe Associates Inc | Buy | +27,909 | — | 27,909 | $135.00K | Q2 2026 | Aug 14, 2026 |
| Xtx Topco Ltd | Buy | +27,235 | +120.0% | 49,923 | $240.13K | Q2 2026 | Aug 14, 2026 |
| Murchinson Ltd. | Sell | -25,000 | -1.9% | 1,290,294 | $6.21M | Q2 2026 | Aug 14, 2026 |
| Invesco Ltd. | Buy | +24,751 | — | 24,751 | $119.05K | Q2 2026 | Aug 14, 2026 |
| Boothbay Fund Management, Llc | Sell | -22,078 | -3.7% | 578,638 | $2.78M | Q2 2026 | Aug 14, 2026 |
| Mirae Asset Global Etfs Holdings Ltd. | Buy | +15,671 | — | 15,671 | $75.38K | Q2 2026 | Aug 14, 2026 |
| Engineers Gate Manager Lp | Buy | +12,698 | — | 12,698 | $61.08K | Q2 2026 | Aug 14, 2026 |
| Barclays Plc | Sell | -12,429 | -62.3% | 7,537 | $36.25K | Q2 2026 | Aug 14, 2026 |
| Wells Fargo & Company/Mn | Buy | +8,414 | +5.3% | 166,000 | $798.46K | Q2 2026 | Aug 14, 2026 |
| Millennium Management Llc | Buy | +5,843 | +36.5% | 21,861 | $105.15K | Q2 2026 | Aug 14, 2026 |
| Bank Of America Corp | Buy | +4,542 | +3.1% | 150,694 | $724.84K | Q2 2026 | Aug 14, 2026 |
| Legal & General Group Plc | Buy | +3,322 | — | 3,322 | $15.98K | Q2 2026 | Aug 14, 2026 |
| Prelude Capital Management, Llc | Sell | -2,600 | -7.4% | 32,713 | $157.35K | Q2 2026 | Aug 14, 2026 |
| Royal Bank Of Canada | Buy | +2,413 | +1386.8% | 2,587 | $12.00K | Q2 2026 | Aug 14, 2026 |
| Metlife Investment Management, Llc | Buy | +1,463 | — | 1,463 | $7.04K | Q2 2026 | Aug 14, 2026 |
| Jones Financial Companies Lllp | Sell | -719 | -77.1% | 214 | $999.00 | Q2 2026 | Aug 14, 2026 |
| Osaic Holdings, Inc. | Sell | -107 | -2.5% | 4,217 | $20.28K | Q2 2026 | Aug 14, 2026 |
| Vanguard Portfolio Management Llc | Buy | +229,882 | — | 229,882 | $1.11M | Q2 2026 | Aug 13, 2026 |
| Northern Trust Corp | Buy | +184,920 | — | 184,920 | $889.47K | Q2 2026 | Aug 13, 2026 |
| Marshall Wace, Llp | Sell | -157,658 | -60.7% | 101,953 | $490.39K | Q2 2026 | Aug 13, 2026 |
| Ubs Group Ag | Buy | +56,004 | +480.0% | 67,671 | $325.50K | Q2 2026 | Aug 13, 2026 |
Frequently asked questions about ORMP activity
Which institutional owners are buying ORMP?
Institutional owners buying ORMP include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.
What does "buy" mean in ORMP activity?
"Buy" means an investor increased their reported position in ORMP compared to the prior reporting period. This reflects growing exposure to ORAMED PHARMACEUTICALS INC (ORMP) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).
Is institutional interest in ORMP increasing?
Institutional interest in ORMP can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.
Related ORMP Institutional Insights
- ORMP Overview
- ORMP 13F Institutional Holders
- ORMP Top Institutional Shareholders
- Healthcare Sector Institutional Ownership
- Healthcare Sector Portfolio Overlap
- Institutional Portfolio Overlap & Shared Holdings
- Most Bought Healthcare Stocks By Institutional Investors
- Most Sold Healthcare Stocks By Institutional Investors
- ORMP Insider Trading & SEC Form 4 Activity
- ORMP Articles
- Top Institutional Investor Stock Rankings